dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Medina, Alejandro |
dc.contributor.author | Jimenez, Cristina |
dc.contributor.author | Sarasquete, Maria Eugenia |
dc.contributor.author | González, Marcos |
dc.contributor.author | Chillón, M. Carmen |
dc.contributor.author | Balanzategui, Ana |
dc.contributor.author | Gironella Mesa, Mercedes |
dc.date.accessioned | 2021-09-09T05:52:15Z |
dc.date.available | 2021-09-09T05:52:15Z |
dc.date.issued | 2020-02-06 |
dc.identifier.citation | Medina A, Jiménez C, Sarasquete ME, González M, Chillón MC, Balanzategui A, et al. Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients. Blood Cancer J. 2020 Feb 6;10:14. |
dc.identifier.issn | 2044-5385 |
dc.identifier.uri | https://hdl.handle.net/11351/6280 |
dc.description | Investigació genètica; Mieloma |
dc.description.sponsorship | This work was partially supported by the Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Economy and Competitiveness PI15/01956, CIBERONC-CB16/12/00233, and “Una manera de hacer Europa” (Innocampus; CEI-2010-1-0010)”. M.G.-A., I.P.-C., and C.J. are supported by the Fundación Española de Hematología y Hemoterapia (FEHH, co-funded by Fundación Cris in the latter case), A.M. by the European Social Fund and the Spanish Education Council through the University of Salamanca, and M.E.S. by the ISCIII (CPII18/00028). All Spanish funding is co-sponsored by the European Union FEDER program. The authors wish to thank José Pérez, Alicia Antón, Montserrat Hernández-Ruano, Estrella Arnés, Rebeca Maldonado, Mercedes Jiménez, Alejandra Martín, Isabel Sánchez, Rocío Corral and Francisco Boix (University Hospital of Salamanca, Spain) for their technical support, as well as the Spanish Multiple Myeloma “GEM-PETHEMA” group for providing clinical data. The authors are also very grateful to the patients who participated in this study. |
dc.language.iso | eng |
dc.publisher | Springer Nature |
dc.relation.ispartofseries | Blood Cancer Journal;10 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Mieloma múltiple |
dc.subject | Regulació genètica |
dc.subject.mesh | Multiple Myeloma |
dc.subject.mesh | Gene Expression Regulation, Neoplastic |
dc.title | Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1038/s41408-020-0283-8 |
dc.subject.decs | mieloma múltiple |
dc.subject.decs | regulación de la expresión génica neoplásica |
dc.relation.publishversion | https://doi.org/10.1038/s41408-020-0283-8 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Medina A, Jiménez C, Sarasquete ME, González M, Chillón MC, Balanzategui A] Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain. [Gironella M] Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 32029700 |
dc.identifier.wos | 000512747500001 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI15%2F01956 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/CB16%2F12%2F00233 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/CPII18%2F00028 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |